Akriderm cream naruzhn.prim-I 0.05% 30g tube

Description

Composition
Active substance:
100 g of cream contains:: betamethasone dipropionate in terms of 100% substance – 0,064 g, equivalent to 0.05 g of betamethasone ;.
Excipients:
Methyl parahydroxybenzoate – 0.2 g solid paraffin – 9 g Vaseline – 3 g; propylene glycol – 5 g; Liquid paraffin – 18 g; wax emulsion – 7 g; Disodium edetate – 0.1 g; sodium sulfite – 0.05 g; Purified water – up to 100 g
Description:
Cream, white or nearly white.
Product form:
Cream for external use 0.05%. 15, 30 or 50 g in a tube of aluminum. Each tube together with instructions for use in a stack of cardboard.
Contraindications
Hypersensitivity to betamethasone or other drug compounds. Bacterial (lupus, cutaneous manifestations of syphilis), fungal, viral (varicella, herpes simplex), skin disease, skin reactions after vaccination,
open wounds, leg sores, rosacea, acne vulgaris, skin cancer, mole, atheroma,
melanoma, hemangioma, xanthoma, sarcoma, lactation and children under 1 year.
Carefully
With prolonged use, or applied to a large surface: cataract, diabetes, glaucoma, tuberculosis.
Dosage
0.64 mg / g
Indications
Skin diseases amenable to glucocorticosteroid therapy: atopic dermatitis; allergic contact dermatitis; eczema (various forms); contact dermatitis (including professional) other non-allergic dermatitis (including solar radiation and dermatitis); reactions to insect stings; psoriasis; bullous dermatoses; discoid lupus erythematosus; lichen planus; mnogomorfnaya exudative erythema; itching of various etiology.
Interaction with other drugs
Drug interactions with the other drug is not revealed.
Overdose
Acute overdose is highly unlikely, however, the excessive use of the drug will be available ilidlitelnom chronic overdose accompanied by signs of Cushing: hyperglycemia, glycosuria, reversible depression of adrenocortical function, a manifestation of Cushing’s syndrome. Treatment: It is recommended a gradual withdrawal of the drug and, if necessary, provedeniesimptomaticheskogo treatment.
pharmachologic effect
Pharmacodynamics:
Akriderm® – glucocorticosteroid for outdoor use. Has anti-inflammatory, anti-allergic, antiekssudativnoe, sosudo-
narrows, antipruritic, and antiproliferative effects. Inhibits nakoplenieleykotsitov, release of lysosomal enzymes and proinflammatory mediatorovv the inflammation inhibits phagocytosis, reduced vascular tissue permeability,
It prevents the formation of inflammatory edema. When applied to the skin surface and the drug has a rapid dramatic effect in inflammation, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).
Pharmacokinetics:
When cutaneous application of the drug at therapeutic doses transdermal absorption of the active substance in the blood is very small. The use of occlusive dressings, skin diseases and inflammation povyshaettransdermalnoe betamethasone absorption, which can lead to an increase riskarazvitiya systemic side effects.
Pregnancy and breast-feeding
topical glucocorticosteroids safety has not been established in pregnant women; prescription drugs of this group during the period of pregnancy is justified only if the potential benefit to the mother outweighs the potential risk to the fetus. During pregnancy, this group of drugs should not be used in high doses or for long periods. If necessary, use during lactation should stop breastfeeding.
Conditions of supply of pharmacies
Without recipe.
side effects
As a rule, it has slight character.
When external application of glucocorticosteroids can be observed: itching, burning sensation, irritation, dryness, folliculitis, hypertrichosis, striae, aknepodobnye rash ( “steroid” blackheads), hypopigmentation, perioral dermatitis, allergic contact dermatitis. With prolonged use, and the use of occlusive dressings – maceration of the skin, secondary infection, skin atrophy, local hirsutism, telangiectasia, heat rash, purpura. When applied to a broad surface of the body, mainly in children, may cause systemic side effects of glucocorticoids (hyperglycemia, glycosuria, reversible depression of adrenocortical function, a manifestation of Cushing’s syndrome).
When adverse reactions not described in the instructions, you should consult a doctor.
special instructions
We do not recommend prolonged use of the drug in the outer kozhelitsa as possible the development of rosacea, perioral dermatitis and acne. lecheniyane rate should exceed 5 days. Akriderm® cream is not intended for use in ophthalmology. Avoid popadaniyapreparata eyes. If the product enters the mucous membrane of the eye vozmozhnorazvitie cataract, glaucoma, fungal infections and eye aggravation gerpeticheskoyinfektsii. For prolonged treatment, when applied to the preparation extensive skin surface,
as well as in the armpits and groin folds, using okklyuzionnyhpovyazok, diapers, possible systemic absorption of corticosteroids. Children from 1 year the drug is prescribed only under strict indications and under medical supervision, as may develop systemic side effects associated with betamethasone. In applying the ointment in children aged 1 year and older is necessary to limit the total duration of treatment and exclude activities leading to increased bone resorption and absorption (Warming, fixing and occlusive dressings, diapers) .If use of the drug over a large surface and / or under occlusive povyazkoyvozmozhno suppression function hypothalamic-pituitary-adrenal system irazvitie symptoms of Cushing, you may experience slow excretion gormonarosta, increased intracranial pressure.
Effects on ability to drive vehicles, machinery.
Does not affect.
Storage conditions
At a temperature of 15 to 25 C.
Keep out of the reach of children.
Dosing and Administration
Outwardly. Akriderm® cream is applied thinly to the affected area 2 times a day – morning and evening, gently rubbing. In areas with thicker skin (e.g., elbows, hands and feet), and the location from which the drug is easily erased,
Akriderm® cream can be applied more often. The duration of treatment depends on the efficacy and tolerability of therapy and is typically no more than 4 weeks. During the year, the possibility of multiple repetition of therapy.
Akriderm® cream is used to treat in ostrovospalitelnuyu phase of the disease, including weeping skin lesions.
In children and in patients with lesions of the skin treatment should not exceed 5 days.
If clinical improvement does not occur, it is necessary to specify the diagnosis.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist